BioMark Diagnostics Inc C.BUX

Alternate Symbol(s): BMKDF

Healthcare Diagnostics & Research

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.

CSE:BUX - Post by User

BioMark Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

(54)
•••

Post by geodcanon Feb 15, 2023 4:06pm

183 Views

Post# 35288347

I've got a serious volume bid

in for some more BUX albeit at what I consider a fairer value but still a 5 figure investment on the specualtion that they can spark this up one more time.

200k or 400k shares. I can't remember what amount I bid on.

<< Previous

Bullboard Posts

Next >>

AI development deal set to model real-world infrastructure